Buy Hold Sell: 5 ASX tech stocks powering through AI panic
As anyone paying even cursory attention to markets would know, the ASX tech sector has had a rough trot over the past year, down 37% as AI upheaval and rising rates took their toll.
But not every stock in the sector has been dragged down with it, and the upcoming August reporting season is shaping up as a key test of who's actually benefiting from AI versus who's being eaten by it.
In this episode of Buy Hold Sell, Elise McKay of Pendal and Shaun Weick of Wilson Asset Management join Livewire's Tom Stelzer to analyse three of the biggest ASX tech names that each sit on different branches of the AI tree.
One is a standout performer up more than 70% year-to-date, one is a software name some have already declared dead as an AI casualty, and one is a data centre name smack bang in the middle of the infrastructure boom.
They also each nominate a tech stock they're backing, including one that could be the next big Australian medtech success story.
Let's jump in.
This episode was filmed Wednesday 15th July, 2026.
Other ways to listen
Spotify- Podbean
Edited transcript
Before I get to the stocks, I've got a couple of questions for you guys. Shaun, I might come to you first. Given the weak performances seen from the tech sector over the last 12 months, would you say the sector is opportunity rich, or still at risk of disruption right now?
I think the good thing now is we've reached I think a point in time where the market is willing to start to differentiate the winners and losers from AI in particular. And as a result of that, we are seeing some opportunities in the tech sector. And in particular, leaning into those aspects where we do think they are beneficiaries. We do think those that look challenged or at risk of disruption from AI still look challenging.
Elise McKay: I'm very much focused on software and what could be a catalyst to unlock some of the upside that I think is in that sector. And so what am I focused on for a catalyst? I'm focused on anything that can either disprove that AI is a threat or prove that software, in fact, could be a beneficiary of AI. So it's things like on the top line I'm looking for, can we see AI product actually be monetised and add new revenue? How are we seeing AI impact churn trends? Does subscriber number's still growing? How does this translate to revenue growth?
Then if I think through to the margin side, margins could go two ways. So firstly on the AI as a threat side, do we see margin pressure when you're selling AI product? That is you sell a product, you've got a draw on token. So every time you use the product, it's got a cost associated with it, so it's lower margin product versus AI is inherently scalable. Sorry, software is inherently scalable. You build once, you sell many times. So it's a very high margin product. And so then, do we see margins actually potentially even improve? As software companies, they have large human capital, they've got a lot of people, a lot of software developers. So can they actually harness AI productivity gains which could drop through to margin improvement?
And then finally, we're really focused on those businesses which do need to change their pricing models. A lot of software doesn't in Australia. They're not linked to seat-based consumption or seat-based models, but we do see the likes of WiseTech. We want to see how successful they are at migrating that business away from seat-based fees to consumption-based.
Megaport (ASX: MP1)
Tom Stelzer: You've both touched on AI there. It's pretty much unavoidable at the moment and it leads us nicely into the stocks. Elise, I might stay with you. Our first stock is Megaport. It's one of the ASX best performers this year. I think it's up 73% year to date. Are you a buy, hold, or sell on Megaport?
Elise McKay: (HOLD) I'm a hold. I mean, this has been a tremendous turnaround and I am a great admirer of the business. The team, so Michael came into the business three years ago, turned around the product strategy. He reinvested in go-to-market and actually accelerated the core underlying network business. So that is a business that is in much better shape than it was three years ago.Then one of the unappreciated assets of this business I think has always been that it's had this 1,000 data centre network distributed globally. And finally, with the acquisition of Latitude last year is actually able to monetise that asset base. And so what they are doing is they are effectively shifted into selling compute, GPU, CPU as a service. And they've signed a number of transactions recently, which are very much value accretive. That's driven earnings momentum, that has been very returns accretive and driven significant earnings upgrades for the business.
So we very much like the business. We liked it when they did the equity raise a month or two ago to support that business, but the stocks run really hard since then and north of $20 a share. Unfortunately, I'm a hold. It's a business that I really admire. I really like it, but at current prices, I do think there's better value elsewhere.
Shaun Weick: (BUY) We're a buy. Michael's done a tremendous job with the business. We rate him as among the highest quality CEOs within the tech space on the ASX. You touched on a good point there. There's very limited ways to directly play the AI theme within Australia. So as a result of that, you do tend to see crowding towards areas where you are exposed to that particular theme. And we think these guys are in the sweet spot at the moment.
The networking business is benefiting significantly, we think, from cross-sell opportunities with Latitude. The other point I think that is probably understated here is the ability for these guys to continue to go and win very large contracts. They've got about 300 to 400 million of existing liquidity, but our industry feedback suggests they're in the market for over a billion dollars of debt.
If you look at how these businesses structured offshore and if you back solve typical IRR that they're getting on their bare metal computer around that 20% to 30%, that implies substantial earnings upgrades as they come through and execute on these contracts. And we don't think demand's a problem at all. It trades on half the valuation of its peer in the US digital ocean. So, yeah, we still really like it here.
TechnologyOne (ASX: TNE)
Shaun Weick: (BUY) We're a buy there. We think TechOne's actually done a great job in terms of crafting the narrative towards being a beneficiary of AI. You look at some of the products that they're building and their ability to monetise that in the market. We think they are putting evidence on the board.
So, yeah, Edward's done a great job in terms of how he's continued to try and lean into that theme. And I think going forward, to the point around concentration within the ASX and a lack of alternatives, we think this is one that people will gravitate towards. As a result of that, it is likely to stay on a premium multiple, so we're buy.
Elise McKay: (BUY) We're also a buyer. So this is a business that I followed for a long time and I'm constantly impressed by their ability to be consistent. So they've consistently grow that top line, 16% to 18% ARR growth. They continue to eke out some margin improvement. That's translating to 20% EPS growth compounding, which should more than double the business every five years. So they've got a very sticky customer base with local councils, student management, government and the expansion into the UK. So they've had a lot of success recently and gaining really good traction in that market. So that expands the addressable market over the long term. So we really like that long pathway for growth.
And when I think about the multiple, it is trading on high 20s EBITDA multiples. So it's certainly expensive or at the expensive end, but the market does typically pay up for quality, particularly also for consistency. And so for that reason, we think that whilst it's expensive, it's less expensive than what it has been up in the 40s historically. And so therefore it's a buy. You don't often get a chance to buy quality or growth cheap, but you can buy it less expensive and that's where we are today.
NEXTDC (ASX: NXT)
And so NEXTDC as one of the leading players of the market with a great quality portfolio, attractive land bank and really strong relationships with top tier clients is really positioned well to benefit from that over the long term. So we are a buyer.
And one other thing I would just add on data centres, why do we like data centres? So they have low cost of capital businesses. You can put a lot of leverage into them to invest in long-lived infrastructure assets. They then go and sell that data centre capacity to blue chip, AAA, A rated clients with long leases at mid-teen levered returns. So you're getting a really nice incremental return on that capital that's being invested. And that's really at the heart of why we like data centres as a space.
And then if I layer on top of that for NEXTDC specifically, if I think about the valuation, I think it's very much an asymmetric risk story to the upside. The downside is protected by its replacement value. So when you get around $10, $11, very conservatively see that trading around replacement value. At those levels, someone would just come in and snap it up. That's how strong demand is for data centres globally. And then you've got a really strong pipeline which will grow the upside.
And at today's valuations, it's trading at around 17 times contracted EBITDA. EBITDA today is about 240 million. They've contracted over a billion dollars of EBITDA and transactions typically occur at 24 times EBITDA. So there's a really strong valuation case there as well.
And then if you look forward, we think there's some really exciting growth opportunities across the broader HMC platform in terms of what they could do with the energy transition platform down in Victoria where they have access to significant battery and wind, which we've heard from Albo today is going to be critically important for data centres going forward to build another facility and effectively add what will be a pretty strong growth layer to this business.
And then I think the other key thing is just looking at an evaluation point of view. It trades on half the multiple of NEXTDC. And on an NTA basis, it's about a 40% discount. So yeah, we think it looks attractive here.
Guest picks
Tom Stelzer: We've also asked our guests to bring one ASX tech stock there back in for the near future. Shaun, might come back to you. What do you got for us?
Artrya (ASX: AYA)
Shaun Weick: One we really like at the moment's Artrya, stock code is AYA. So these guys are essentially building a diagnostic platform that effectively looks at plaque and soon to be flow within the heart valves. So the business has done a very good job in terms of gaining those initial FDA approvals around plaque. We think the approval for the flow module is imminent.They're building out a really strong pipeline of hospitals to continue to penetrate that US market, which we think will serve as really strong catalysts in the near term. Yeah, we see this as the next Pro Medicus on the Australian market. From all the feedback we've had from customers within the US, this is the gold stand within the industry. They're materially outperforming HeartFlow and clearly their main competitor. So, yeah, we think they're really well-placed over the next three to five years to generate some very strong growth.
Xero (ASX: XRO)
Tom Stelzer: Elise, Shaun has given us med-tech there. What have you got for us?
Elise McKay: Well, we started by talking about how AI is a technological change and that there will be winners and losers. So I think the stock that has been thrown in that losers category, but I think it's actually a winner, and why do I think that it's a winner is Xero. And so this is when you look at what will define the winners from the losers, I think it will come down to execution. The companies that execute well are best positioned to take advantage of AI as an opportunity.And Xero is executing incredibly well. They're accelerating growth in the US. So they're gaining cost efficiency, so they're improving their margin. The product's getting better and better all the time. They've got a great AI product strategy. And then when I think about the valuation, oh my goodness, it is cheap no matter how I look at it, trading sub 15 times NTM EBITDA. If I do a reverse DCF, it's trading as if it has no future growth being priced in. And this is a business that has an ability to grow north of 20% CAGR top line over the long term.
And then finally, if you think about the cost of actually building the Xero platform, going out and winning almost five million subscribers globally, building a distribution network of over 250,000 accountants globally, I think the replacement costs would be close to where the stock's actually trading today. So for me, that's why Xero is the winner.
4 topics
5 stocks mentioned
4 contributors mentioned